Advertisement
Screener

Vaxart, Inc. (VXRT) Effective Tax Rate

2.8 / 5 stars · 68/120 Roast Me

Vaxart, Inc. Effective Tax Rate

Vaxart, Inc. (VXRT) reported Effective Tax Rate of 2.80% for the 12-month period ending 2025-12-31, per its S-1 filed 2026-05-08.

Financial Statements › Expense Statement › Income Tax

us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-05-08

  • Vaxart, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.30%, a 200.00% increase from fiscal 2022.
  • Vaxart, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.10%.
  • Vaxart, Inc. effective income tax rate reconciliation, percent for fiscal 2021 was -0.10%.
  • Vaxart, Inc. effective income tax rate reconciliation, percent for fiscal 2020 was -0.70%.
Period endEffective Income Tax Rate Reconciliation, Percent 12 monthEffective Income Tax Rate Reconciliation, Percent 12 month as first filed
2025-12-312.80%
S-1 · filed 2026-05-08
2024-12-31-0.40%
S-1 · filed 2026-05-08
0.40%
10-K · filed 2025-03-20
2023-12-310.30%
10-K · filed 2025-03-20
2022-12-310.10%
10-K · filed 2024-03-14
-0.10%
10-K · filed 2023-03-15
2021-12-31-0.10%
10-K · filed 2023-03-15
2020-12-31-0.70%
10-K · filed 2022-02-24
2019-12-31-2.70%
10-K · filed 2022-02-24
2018-12-31-0.60%
10-K · filed 2021-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
EXOZYMES INC. (EXOZ)United States$0.058B